Life Science Technical Accounting CPE Update 2024 is a conference dedicated to the latest developments, accounting changes, standards and key factors affecting the life science industry.
Topics
- R&D Funding Arrangements
- Accounting for R&D and Clinical Trials
- SEC Comment Letter Trends
- R&D Cost Classifications
- Latest legislative developments
- Tax Update
- Build Back Better Act Observations
- Key Tax Proposals
- Revenue Recognition: Evolving Issues - Life Sciences
- Possible timing and other legislative priorities
- Performance Obligations
- Scope of Contract
- Collaboration agreements
- Nature of promise: sales of points
- Gross vs Net
- Sales using third party platforms
- M&A in Life Sciences
- Counterparty Perspective
- Accounting Considerations
- Industry Trends
- Accounting Insights
- IPR&D and Intangible Assets
- Royalty Monetization
- Financing Trends
- Accounting Considerations
- Convertible Debt
- Convertible structure in the life science financing cycle
- When should companies consider convertible debt?
- IPOs: Trends and Accounting Considerations
- Changes of control, tax implications, size, maturity and other questions
- Practical insights on accounting step
- Other Intangible Assets
Who should Attend
- Controllers
- CFOs (and their staff)
- Financial Managers
- VPs of Finance
- Tax Accountants
- Internal Auditors
- Accountants in Industry
- Treasury Staff
- Consultants
- Internal Control/SOX personnel
- Educators
- Public Accountants
